Clinical Trial Update: Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma

View source ↗

Summary

A recruiting study at University Hospital, Bordeaux aims to characterize metabolic, transcriptomic, and proteomic features of relapsed glioblastoma (IDH-wildtyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Relapsed Cancer, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype | Status: RECRUITING